Lipocalin-2 may stimulate the IL-12/STAT4 signaling pathway, which promotes upregulation of IFN-γ expression on CD4 cells and their differentiation into Th1 cells and leads to kidney involvement in SLE [168]. Here, CD4 is linked to systemic lupus erythematosus.